For the first time in 14 years, doctors have updated guidelines for preventing migraine attacks.
The new recommendations from the American Academy of Neurology and American Headache Society, published August 31 in Neurology, incorporate evidence on treatments that weren’t available when the guidelines were last updated. That includes drugs that target calcitonin gene-related peptide, or CGRP. These drugs, like Aimovig and Ajovy, have been a game changer for some, reducing migraines in up to 70 percent of the people who take them.
We summarize the week’s scientific breakthroughs every Thursday.
Some come in tablet form, while others are injected…
Read the full article at SCIENCENEWS.ORG
